Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2020-12-03 Regulatory Filings
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security, referencing the 'RNS Number' and stating that the information is provided by 'RNS, the news service of the London Stock Exchange.' This structure—a brief notification about a market event or administrative update distributed via the RNS system, rather than a comprehensive financial report (like 10-K, IR, or ER)—fits the definition of a general regulatory announcement or miscellaneous filing. Since it is a direct, short announcement distributed through the official regulatory news service (RNS), and doesn't fit any other specific financial reporting category (like DIV, DIRS, or ER), the most appropriate classification is the general Regulatory Filings category.
2020-12-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 4940H' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, time-sensitive operational announcement related to trading halts or volatility controls. This type of general regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing category, RNS, as per the definitions and the 'Menu vs Meal' rule (it's an announcement, not a detailed report).
2020-12-03 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and contains the header 'RNS Number : 4923H' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, brief operational announcement related to trading mechanics, not a comprehensive financial report or a standard corporate action like a dividend or management change. Since it is a general regulatory announcement distributed via the RNS system that doesn't fit into the more specific categories (like ER, 10-K, DIV, etc.), the most appropriate classification is the general regulatory filing fallback category.
2020-12-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document contains the header 'RNS Number : 4567H' and explicitly mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' It details a 'Second Price Monitoring Extension' related to trading activity, which is a type of regulatory market announcement. Since it is a specific regulatory announcement that doesn't fit the definitions for ER, IR, 10-K, or other specific corporate actions, and it is clearly sourced from the RNS system, the most appropriate classification is Regulatory Filings (RNS). The document length is short (1931 chars), but it is the primary content itself, not an announcement *about* another report, thus RPA is less suitable than RNS for this specific market event notification.
2020-12-03 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly mentions 'RNS Number', 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom', and ends with an RNS-specific identifier ('PMEEAFADEEEEFFA'). The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security on the London Stock Exchange. This is a general regulatory announcement that does not fit into specific financial reporting categories like 10-K, ER, or IR. Therefore, it falls under the general Regulatory Filings category.
2020-12-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, time-sensitive operational announcement related to trading halts or volatility controls on the exchange. This type of general regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing category, RNS (Regulatory News Service). The document length is short (1931 chars), but it is the primary announcement itself, not an announcement *about* another report.
2020-12-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.